The Gain Train

The Gain Train

S23

S23 is offered in 33mg per ml for 30ml, totaling 1000mg.

According to the available studies, S23 induced infertility in all rats it was exposed to. These effects are dose-dependent and temporary, meaning the rats regained fertility following treatment. This shows potential of S23 as an oral male contraceptive.

According to the research, S23 subdues serum concentration of luteinizing hormone and follicle-stimulating hormone to produce biphasic effects on spermatogenesis. Additional research and clinical trials should be conducted to determine the efficacy and safety of S23 is as an oral contraceptive.

The above-mentioned study produced other beneficial desirable effects. For instance, researchers observed a stronger affinity to androgen receptors as compared to other popular compounds like Andarine. It also has an ideal anabolic-androgenic ratio allowing it to produce a good number of positive effects without any severe complications. One of those effects was increasing bone mineral density and lean muscle mass.

Therefore, while S23 may be effective as a male birth control pill, it can also be used for other purposes, especially among patients with chronic conditions that lead to muscle wasting.

S23
CAS Number	1010396-29-8
Molar Mass	416.76 g·mol−1
Chemical Formula	C18H13ClF4N2O3
IUPAC Name	(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

LGD 4033

LGD 4033 is offered in 67mg per ml for 30ml, totaling 2000mg.

Ligandrol is a novel nonsteroidal oral selective androgen receptor modulator currently being investigated in research as a potential treatment for conditions relating to muscle dystrophy and osteoporosis.

Recent studies investigated the effects of LGD 4033 on muscle tissue in ovariectomized rats. A daily dose of LGD was administered and calculated according to body weight of each individual rat at the onset of the study. Results and changes were noted as soon as week 2, the control group having weighed significantly less than rats undergoing LGD treatment. This difference remained until the end of the study, irrespective of LGD treatments. Additionally, the LGD treatments resulted in a higher number of capillaries in all muscles studied. Longer randomized trials and research could potentially evaluate its efficacy in improving physical function and health outcomes in select populations.

LGD-4033
CAS Number	1165910-22-4
Molar Mass	338.253 g·mol−1
Chemical Formula	C14H12F6N2O
IUPAC Name	4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile

Please note, packaging might differ slightly as we update our packaging and labels. Please research the scientific uses of this product and read our TERMS AND CONDITIONS before completing your purchase.
By completing and paying for your order, you agree to our Terms and Conditions.  Customer satisfaction is our number one priority, if you are not 100% satisfied with the product you received, please contact us at support@purerawz.co
We are not affiliated, associated, authorized, endorsed by, or in any way officially connected with SARMScentral.org, or any of its subsidiaries or its affiliates.